this post was submitted on 16 Nov 2023
89 points (100.0% liked)
science
14436 readers
157 users here now
just science related topics. please contribute
note: clickbait sources/headlines aren't liked generally. I've posted crap sources and later deleted or edit to improve after complaints. whoops, sry
Rule 1) Be kind.
lemmy.world rules: https://mastodon.world/about
I don't screen everything, lrn2scroll
founded 1 year ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
This gene is already targeted by injected drugs but they are very expensive.
"PCSK9 has medical importance because it acts in lipoprotein homeostasis. Agents that block PCSK9 can lower LDL particle concentrations. The first two PCSK9 inhibitors, alirocumab and evolocumab, were approved as once every two week injections, by the U.S. Food and Drug Administration in 2015 for lowering LDL-particle concentrations when statins and other drugs were not sufficiently effective or poorly tolerated. The cost of these new medications, as of 2015, was $14,000 per year at full retail; judged of unclear cost effectiveness by some."